A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Trial Identifier: D7830C00002
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT04483947
Start Date: November 2020
Primary Completion Date: December 2023
Study Completion Date: December 2023
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
MX Ciudad de México, MX, 06700
MX D.F, MX, 14000
MX Mexico D.F., MX, 014080
US, AZ Chandler, AZ, US, 85224
US, AZ Scottsdale, AZ, US, 85258
US, CA Anaheim, CA, US, 92801
US, CA Chula Vista, CA, US, 91911
US, CA Coronado, CA, US, 92118
US, CA La Mesa, CA, US, 91942
US, CA Montclair, CA, US, 91763
US, CA San Diego, CA, US, 92103
US, DC Washington, DC, US, 20007
US, FL Doral, FL, US, 33166
US, FL Hialeah, FL, US, 33014
US, FL Hialeah, FL, US, 33016
US, FL Miami Lakes, FL, US, 33014
US, IN Indianapolis, IN, US, 46202
US, MA Boston, MA, US, 02118
US, NC Morehead City, NC, US, 28557
US, North Carolina Durham, North Carolina, US, 27710
US, NY Manhasset, NY, US, 11030
US, OH Columbus, OH, US, 43213
US, PA Hershey, PA, US, 17033
US, TX Arlington, TX, US, 76012
US, TX Dallas, TX, US, 75203
US, TX San Antonio, TX, US, 78229
US, TX San Antonio, TX, US, 78215